shareholder action group, page-6

I don�t think people should worry too much about finding new directors if the bid fails, or even management and a CSO if it came to that.
The Quantiferon test is a basic measurement of a basic part of the immune response and no highly specialized knowledge is required to understand it. In other words, we don�t need highly specialized people. Australia is strong in immunology and has plenty of talent in that area. In addition, CST has some excellent researchers besides its 2 founders and sometimes, its better to have younger minds coming up with the ideas.
Certainly, I have a board member suggestion already.